IBDEI0AW ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5094,1,2,0)
 ;;=2^312.39
 ;;^UTILITY(U,$J,358.3,5094,1,5,0)
 ;;=5^Trichotillomania
 ;;^UTILITY(U,$J,358.3,5094,2)
 ;;=^87511
 ;;^UTILITY(U,$J,358.3,5095,0)
 ;;=704.02^^39^424^4
 ;;^UTILITY(U,$J,358.3,5095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5095,1,2,0)
 ;;=2^704.02
 ;;^UTILITY(U,$J,358.3,5095,1,5,0)
 ;;=5^Telogen Effluvium
 ;;^UTILITY(U,$J,358.3,5095,2)
 ;;=^295751
 ;;^UTILITY(U,$J,358.3,5096,0)
 ;;=V82.0^^39^425^1
 ;;^UTILITY(U,$J,358.3,5096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5096,1,2,0)
 ;;=2^V82.0
 ;;^UTILITY(U,$J,358.3,5096,1,5,0)
 ;;=5^Spec Scr for Skin Cond
 ;;^UTILITY(U,$J,358.3,5096,2)
 ;;=^295694
 ;;^UTILITY(U,$J,358.3,5097,0)
 ;;=V76.43^^39^425^2
 ;;^UTILITY(U,$J,358.3,5097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5097,1,2,0)
 ;;=2^V76.43
 ;;^UTILITY(U,$J,358.3,5097,1,5,0)
 ;;=5^Screen for Malignant Skin Neoplasm
 ;;^UTILITY(U,$J,358.3,5097,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,5098,0)
 ;;=173.00^^39^426^1
 ;;^UTILITY(U,$J,358.3,5098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5098,1,2,0)
 ;;=2^173.00
 ;;^UTILITY(U,$J,358.3,5098,1,5,0)
 ;;=5^Malig Neopl Lip NOS
 ;;^UTILITY(U,$J,358.3,5098,2)
 ;;=^340596
 ;;^UTILITY(U,$J,358.3,5099,0)
 ;;=173.01^^39^426^2
 ;;^UTILITY(U,$J,358.3,5099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5099,1,2,0)
 ;;=2^173.01
 ;;^UTILITY(U,$J,358.3,5099,1,5,0)
 ;;=5^BCC of skin of lip
 ;;^UTILITY(U,$J,358.3,5099,2)
 ;;=^340464
 ;;^UTILITY(U,$J,358.3,5100,0)
 ;;=173.02^^39^426^3
 ;;^UTILITY(U,$J,358.3,5100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5100,1,2,0)
 ;;=2^173.02
 ;;^UTILITY(U,$J,358.3,5100,1,5,0)
 ;;=5^SCC of skin of lip
 ;;^UTILITY(U,$J,358.3,5100,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,5101,0)
 ;;=173.09^^39^426^4
 ;;^UTILITY(U,$J,358.3,5101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5101,1,2,0)
 ;;=2^173.09
 ;;^UTILITY(U,$J,358.3,5101,1,5,0)
 ;;=5^Other specified neoplasm of lip
 ;;^UTILITY(U,$J,358.3,5101,2)
 ;;=^340466
 ;;^UTILITY(U,$J,358.3,5102,0)
 ;;=173.10^^39^426^5
 ;;^UTILITY(U,$J,358.3,5102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5102,1,2,0)
 ;;=2^173.10
 ;;^UTILITY(U,$J,358.3,5102,1,5,0)
 ;;=5^Malig neoplasm of eyelid NOS
 ;;^UTILITY(U,$J,358.3,5102,2)
 ;;=^340597
 ;;^UTILITY(U,$J,358.3,5103,0)
 ;;=173.11^^39^426^6
 ;;^UTILITY(U,$J,358.3,5103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5103,1,2,0)
 ;;=2^173.11
 ;;^UTILITY(U,$J,358.3,5103,1,5,0)
 ;;=5^BCC of skin of eyelid/canthus
 ;;^UTILITY(U,$J,358.3,5103,2)
 ;;=^340467
 ;;^UTILITY(U,$J,358.3,5104,0)
 ;;=173.12^^39^426^7
 ;;^UTILITY(U,$J,358.3,5104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5104,1,2,0)
 ;;=2^173.12
 ;;^UTILITY(U,$J,358.3,5104,1,5,0)
 ;;=5^SCC of skin of eyelid/canthus
 ;;^UTILITY(U,$J,358.3,5104,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,5105,0)
 ;;=173.19^^39^426^8
 ;;^UTILITY(U,$J,358.3,5105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5105,1,2,0)
 ;;=2^173.19
 ;;^UTILITY(U,$J,358.3,5105,1,5,0)
 ;;=5^Other specified neoplasm eyelid
 ;;^UTILITY(U,$J,358.3,5105,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,5106,0)
 ;;=173.20^^39^426^9
 ;;^UTILITY(U,$J,358.3,5106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5106,1,2,0)
 ;;=2^173.20
 ;;^UTILITY(U,$J,358.3,5106,1,5,0)
 ;;=5^Malig neoplasm skin, ear/ear canal NOS
 ;;^UTILITY(U,$J,358.3,5106,2)
 ;;=^340598
 ;;^UTILITY(U,$J,358.3,5107,0)
 ;;=173.21^^39^426^10
 ;;^UTILITY(U,$J,358.3,5107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5107,1,2,0)
 ;;=2^173.21
 ;;^UTILITY(U,$J,358.3,5107,1,5,0)
 ;;=5^BCC of skin of ear/ear canal
 ;;^UTILITY(U,$J,358.3,5107,2)
 ;;=^340470
